NAV
$114.91
AUM
$203.2M
Expense Ratio
-
Dividend Yield
3.01%
Beta
0.66
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +0.17% | +5.23% | +8.39% | +0.64% | +4.58% | +2.87% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | NOVO-B.CO | Novo Nordisk AS Class B | 22.17% |
| 2 | DSV.CO | DSV AS | 10.28% |
| 3 | DANSKE.CO | Danske Bank AS | 6.77% |
| 4 | VWS.CO | Vestas Wind Systems AS | 5.17% |
| 5 | NSIS-B.CO | Novonesis (Novozymes) B Class B | 4.35% |
| 6 | GMAB.CO | Genmab AS | 4.03% |
| 7 | ORSTED.CO | Orsted AS | 3.53% |
| 8 | CARL-B.CO | Carlsberg AS Class B | 3.23% |
| 9 | MAERSK-B.CO | A P Moller Maersk AS Class B | 2.59% |
| 10 | NKT.CO | NKT AS | 2.52% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Denmark. The underlying index uses a capping methodology that limits the weight of any single “group entity” to a maximum of 25% of the underlying index weight. The fund is non-diversified.
Inception Date: 2012-01-25